A member of medical staff takes coronavirus test samples of a woman during drive-thru Covid-19) testing in Alkmaar, Netherlands. PHOTO: REUTERS/FILE

Two European patients re-infected with coronavirus

Cases of re-infection has fuelled fears about the effectiveness of potential vaccines against the Covid-19


Reuters August 25, 2020
AMSTERDAM/ BRUSSELS:

Two European patients are confirmed to have been re-infected with the coronavirus, raising concerns about people’s immunity to the virus as the world struggles to tame the pandemic.

The cases, in Belgium and the Netherlands, follow a report this week by researchers in Hong Kong about a man there who had been re-infected with a different strain of the virus four and a half months after being declared recovered - the first such re-infection to be documented.

That has fuelled fears about the effectiveness of potential vaccines against the virus, which has killed hundreds of thousands of people, though experts say there would need to be many more cases of re-infection for these to be justified.

Belgian virologist Marc Van Ranst said the Belgian case was a woman who had contracted Covid-19 for the first time in March and then again in June. Further cases of re-infection were likely to surface, he said.

“We don’t know if there will be a large number. I think probably not, but we will have to see,” he told Reuters, noting that Covid-19 had only been in humans for less than a year.

“Perhaps a vaccine will need to be repeated every year, or within two or three years. It seems clear though that we won’t have something that works for, say, 10 years,” he said.

Van Ranst, who sits on some Belgian Covid-19 committees, said in cases such as the Belgian woman’s in which symptoms were relatively mild, the body may not have created enough antibodies to prevent a re-infection, although they might have helped limit the sickness.

COMMENTS

Replying to X

Comments are moderated and generally will be posted if they are on-topic and not abusive.

For more information, please see our Comments FAQ